Analyst Coverage
| Firm | Analyst | Contact Information |
|---|---|---|
| Auriga USA, Inc. | Raj Mehar, Ph.D. |
P: (212) 231-9057 |
| The Benchmark Company | Derek Taller, Ph.D. |
P: (212) 312-6764 |
| Canaccord Adams | Matthew Scalo |
P: (415) 229-0649 |
| Citigroup | Lucy Lu, M.D. |
P: (212) 816-1441 |
| Cowen & Co. | Ian Sanderson |
P: (617) 946-3922 |
| GARP Research & Securities | Alastair Mackay, Ph.D. |
P: (410) 318-5022 |
| Jefferies & Company | Bruce Cranna |
P: (617) 345-8686 |
| JMP Securities | Charles Duncan, Ph.D. |
P: (212) 906-3510 |
| JP Morgan | Sung Ji Nam |
P: (212) 622-4958 |
| Ladenburg Thalmann & Co. Inc | Kevin DeGeeter |
P: (212) 409-2027 |
| Leerink Swann | Isaac Ro |
P: (212) 277-6040 |
| Morgan Joseph | Shiv Kapoor |
P: (917) 238-8207 |
| Morgan Stanley | Marshall Urist, M.D., Ph.D. |
P: (212) 761-8055 |
| Natixis Bleichroeder | Ashim Anand, Ph.D. |
P: (212) 698-3141 |
| Oppenheimer | Amit Hazan |
P: (212) 667-6144 |
| Piper Jaffray | William R. Quirk, CFA |
P: (612) 303-6858 |
| RBC Capital Markets | Michael Yee |
P: (415) 633-8522 |
| SOLEIL Securities | Junaid Husain |
P: (617) 314-7456 |
| Stephens Inc. | Scott Gleason |
P: (501) 377-2362 |
| UBS | Derik de Bruin, Ph.D. |
P: (212) 713-3964 |
| Wedbush | Kimberly Lee |
P: (415) 274-6842 |
| William Blair & Company | Amanda Murphy |
P: (312) 364-8951 |
Myriad Genetics, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Myriad Genetics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Myriad Genetics, Inc. or its management. Myriad Genetics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.


0.79
